Arcadia Biosciences (RKDA) Depreciation & Amortization (CF) (2014 - 2025)

Arcadia Biosciences has reported Depreciation & Amortization (CF) for 12 years, with the latest figure at $2000.0 in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 105.88% year-over-year to $2000.0; the trailing twelve-month figure through Dec 2025 stood at $32000.0 (down 21.95% YoY), and the FY2025 full-year result was $32000.0, down 44.83% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $253000.0 in Q3 2021, with the low at -$116000.0 in Q4 2023.
• Historically, Depreciation & Amortization (CF) has averaged $75700.0 across 5 years, with a median of $61000.0 in 2023.
• Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) soared 218.92% — and 2023, when it tumbled 236.47%.
• Arcadia Biosciences' Depreciation & Amortization (CF) stood at $192000.0 in 2021, then sank by 55.73% to $85000.0 in 2022, then plunged by 236.47% to -$116000.0 in 2023, then surged by 70.69% to -$34000.0 in 2024, then jumped by 105.88% to $2000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $2000.0 (Q4 2025), $2000.0 (Q3 2025), and $15000.0 (Q2 2025), per Business Quant data.